ArticleExperimental hematology & oncology2026

Efficacy and safety of ruxolitinib for graft-versus-host disease prophylaxis in patients with aplastic anemia undergoing PBSC-only allogeneic stem cell transplantation: a prospective phase II study.

Xiaoyu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.